Mortality in hematologic malignancy and hematopoietic stem cell transplant patients with mucormycosis, 2001 to 2009

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 11, 2011, Pages 5018-5021

  Hammond, Sarah P ^a   Baden, Lindsey R ^a   Marty, Francisco M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; DEFEROXAMINE; POSACONAZOLE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DEBRIDEMENT; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IRON OVERLOAD; LYMPHATIC LEUKEMIA; MALE; MORTALITY; MUCORMYCOSIS; MYELODYSPLASTIC SYNDROME; MYELOID LEUKEMIA; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; AMPHOTERICIN B; ANTIFUNGAL AGENTS; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MUCORMYCOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80054695104     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00536-11     Document Type: Article

References (17)

1. Chamilos, G., R. E. Lewis, and D. P. Kontoyiannis. 2008. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin. Infect. Dis. 47:503-509.
2. De Pauw, B., et al. 2008. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin. Infect. Dis. 46:1813-1821.
3. Greenberg, R. N., et al. 2006. Posaconazole as salvage therapy for zygomycosis. Antimicrob. Agents Chemother. 50:126-133. (Pubitemid 43042912)
4. Hammond, S. P., et al. 2011. Molecular Methods to Improve the Diagnosis and Identification of Mucormycosis. J. Clin. Microbiol. 49:2151-2153.
5. Hammond, S. P., S. Koo, L. R. Baden, and F. M. Marty. 2009. Abstr. 49th Intersci. Conf. Antimicrob. Agents Chemother., abstr. M-1050.
6. Herbrecht, R., et al. 2001. Treatment of 21 cases of invasive mucormycosis with amphotericin B colloidal dispersion. Eur. J. Clin. Microbiol. Infect. Dis. 20:460-466. (Pubitemid 34212106)
7. Imhof, A., S. A. Balajee, D. N. Fredricks, J. A. Englund, and K. A. Marr. 2004. Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole. Clin. Infect. Dis. 39:743-746. (Pubitemid 39180450)
8. Lamaris, G. A., et al. 2009. Increased virulence of Zygomycetes organisms following exposure to voriconazole: a study involving fly and murine models of zygomycosis. J. Infect. Dis. 199:1399-1406.
9. Marty, F. M., L. A. Cosimi, and L. R. Baden. 2004. Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. N. Engl. J. Med. 350:950-952. (Pubitemid 38252550)
10. Pagano, L., et al. 2004. Mucormycosis in hematologic patients. Haematologicaae. 89:207-214. (Pubitemid 38796496)
11. Pagano, L., et al. 2009. Zygomycosis in Italy: a survey of FIMUA-ECMM (Federazione Italiana di Micopatologia Umana ed Animale and European Confederation of Medical Mycology). J. Chemother. 21:322-329.
12. Reed, C., et al. 2008. Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis. Clin. Infect. Dis. 47:364-371. (Pubitemid 352009357)
13. Roden, M. M., et al. 2005. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin. Infect. Dis. 41:634-653. (Pubitemid 41170352)
14. Segal, B. H., et al. 2008. Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria. Clin. Infect. Dis. 47:674-683.
15. Shoham, S., et al. 2010. Primary treatment of zygomycosis with liposomal amphotericin B: analysis of 28 cases. Med. Mycol. 48:511-517.
16. Spellberg, B., et al. 2009. Safety and outcomes of open-label deferasirox iron chelation therapy for mucormycosis. Antimicrob. Agents Chemother. 53:3122-3125.
17. van Burik, J. A., R. S. Hare, H. F. Solomon, M. L. Corrado, and D. P. Kontoyiannis. 2006. Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases. Clin. Infect. Dis. 42:e61-e65.